🔎 Trials Near Me

Hem › Alzheimers sjukdom › Pennsylvania

Kliniska studier för Alzheimers sjukdom i Pennsylvania

24 studier för Alzheimers sjukdom söker deltagare vid platser i Pennsylvania.

Städer i Pennsylvania

Officiell studietext (engelska)

Dominantly Inherited Alzheimer Network (DIAN)

  • University of Pittsburgh, Pittsburgh
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT00869817

A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

  • Flourish Research - Keystone Clinical Studies- Site Number : 8400003, Plymouth Meeting
RekryterarFas 2
Ålder 55 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07688213

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  • Pennsylvania Hospital, Philadelphia
RekryterarFas 2
Ålder 55 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07589595

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  • Flourish Research ? Philadelphia, Plymouth Meeting
RekryterarFas 3
Ålder 50 till 90 · Alla kön · Uppdaterad 21 sep. 2026 · NCT07177352

PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620

  • Perelman Center for Advance Medicine, Philadelphia
RekryterarFas 3Friska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 21 sep. 2026 · NCT05456503

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  • Keystone Clinical Studies, Plymouth Meeting
RekryterarFas 3
Ålder 60 till 85 · Alla kön · Uppdaterad 17 sep. 2026 · NCT06976203

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

  • Hospital of the University of Pennsylvania, Philadelphia
  • Allegheny General Hospital, Pittsburgh
Rekryterar
Ålder 70 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT05929703

Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)

  • University of Pennsylvania, Philadelphia
RekryterarObservationsstudie
Ålder 18 till 120 · Alla kön · Uppdaterad 4 sep. 2026 · NCT05658913

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

  • Thomas Jefferson University - Vickie & Jack Farber Institute for Neuroscience, Philadelphia
RekryterarFas 2
Ålder 55 till 90 · Alla kön · Uppdaterad 1 sep. 2026 · NCT06808984

Biofluid Research on Age-Related or Inherited Neurodegeneration

  • University of Pennsylvania, Philadelphia
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 1 sep. 2026 · NCT07798700

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

  • Flourish Research ( Site 1048), Plymouth Meeting
RekryterarFas 2
Ålder 50 till 85 · Alla kön · Uppdaterad 26 aug. 2026 · NCT07033494

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

  • Penn Medicine, Philadelphia
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 14 aug. 2026 · NCT06377033

The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study

  • University of Pittsburgh, Pittsburgh
Rekryterar
Ålder 55 till 85 · Alla kön · Uppdaterad 6 aug. 2026 · NCT05988385

Evaluating the Effectiveness of the Health App Recommendation Tool

  • University of Pittsburgh, Pittsburgh
RekryterarFriska volontärer välkomna
Ålder 18 till 65 · Alla kön · Uppdaterad 6 aug. 2026 · NCT07216716

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • Penn Presbyterian Medical Center, Philadelphia
  • University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 4 aug. 2026 · NCT06563895

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • University of Pittsburgh, Pittsburgh
RekryterarFas 2/3Friska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 27 juli 2026 · NCT05552157

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • University of Pittsburgh, Pittsburgh
RekryterarFas 2/3Friska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 27 juli 2026 · NCT06647498

Improving Access to Care for Veterans With Memory Loss

  • VA Pittsburgh Healthcare System, Pittsburgh
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 17 juli 2026 · NCT07117162

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  • Abington Neurological Associates Ltd, Willow Grove
RekryterarFas 2
Ålder 50 till 85 · Alla kön · Uppdaterad 26 juni 2026 · NCT07094516

Trial-Ready Cohort-Down Syndrome (TRC-DS)

  • University of Pittsburgh, Co-Enrolling through ABC-DS Only, Pittsburgh
RekryterarObservationsstudie
Ålder 25 till 55 · Alla kön · Uppdaterad 18 maj 2026 · NCT04165109

Late Onset Alzheimer's Disease

  • University of Pittsburgh, Pittsburgh
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 55 och äldre · Alla kön · Uppdaterad 18 maj 2026 · NCT05010603

UPenn Observational Research Repository on Neurodegenerative Disease

  • University of Pennsylvania, Philadelphia
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 22 jan. 2026 · NCT04715399

Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

  • University of Pennsylvania, Philadelphia
RekryterarTidig fas 1
Ålder 40 till 85 · Alla kön · Uppdaterad 23 dec. 2025 · NCT06932809

Impact of a Biophoton Therapy on Patients With Brain Disorders

  • Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001, Butler
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 8 aug. 2025 · NCT06147999

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.